What is the H3N2 (Influenza A) Virus? Symptoms, Diagnosis, and Treatment Methods

What is H3N2 (Influenza A) Virus? What are the Symptoms? How is it Diagnosed and Treated?

The H3N2 virus is a subtype of the influenza A virus and is an infectious agent that affects the respiratory tract. This virus has been observed as the dominant strain in three of the last five flu seasons. H3N2 infection is generally characterized by sudden onset of high fever, muscle aches, and respiratory symptoms.

The H3N2 virus was first identified in humans in 2011 and has continued to cause seasonal flu infections since then. The virus manifests with symptoms such as fever, muscle pain, fatigue, and dry cough. In recent years, some variants of the H3N2 virus can lead to more severe clinical pictures.

Diagnosis of H3N2 infection is usually made with laboratory tests, and treatment is determined based on the severity of the symptoms. More careful monitoring and treatment approaches may be necessary for patients in risk groups. This article provides detailed information on the definition, symptoms, transmission routes, diagnostic methods, and treatment options for the H3N2 virus.

What is the H3N2 Virus?

Understanding the structure and characteristics of the H3N2 virus is crucial to grasping how this infectious agent causes disease. The virus is a subtype of the influenza A virus, belonging to the Orthomyxoviridae family, and is identified by specific proteins found on its surface.

Virus Structure and Classification

The H3N2 virus gets its name from two fundamental proteins on its surface: Hemagglutinin 3 (H3) and Neuraminidase 2 (N2) molecules. The Hemagglutinin protein allows the virus to attach to human cells, while the Neuraminidase protein enables the virus to separate from the cell after replication and infect new cells. These two proteins are essential factors determining the virus’s infectivity and capacity to cause disease.

The virus has the ability to infect both humans and animals. This zoonotic character allows the virus to generate new variants by exchanging genes between different species. The H3N2 virus primarily affects the upper respiratory tract, causing flu-like symptoms, and can often lead to more severe clinical presentations than seasonal influenza cases.

Current Variants and Mutation Characteristics

Since 1968, the H3N2 virus has undergone continuous genetic and antigenic changes to evade the immune system. This evolutionary process has primarily focused on the hemagglutinin protein, altering the virus’s ability to bind to cell receptors. The H3N2 virus has been identified as the dominant strain in three of the last five flu seasons.

A new H3N2 variant that emerged in Australia in 2025 underwent seven significant mutations, causing the flu season to start earlier than expected in many countries. This variant, called subclass K, differs from the reference strain (subclass J.2) selected for the vaccine in February.

The transmissibility rate of the new variant is increasing compared to a normal flu season. For every 100 infected individuals, approximately 140 people can be infected, whereas this number is around 120 during a standard flu season. This increase leads to faster growth of the epidemic wave. In Turkey, a significant rise in case numbers is anticipated starting mid-December, with an intense flu wave expected in January-February.

What are the Symptoms of H3N2 Virus?

Symptoms of H3N2 infection typically appear 1-4 days after contact with the virus, and early diagnosis significantly affects the success of treatment. The severity of symptoms can vary from mild to severe and may be influenced by factors such as the patient’s age and overall health status.

Main Symptoms of H3N2 Infection

The most characteristic symptom of H3N2 infection is a sudden onset of high fever. Body temperature usually rises above 38°C, which is an important finding distinguishing the disease from other upper respiratory tract infections. High fever is often accompanied by severe chills and is generally expected to subside within 3 days.

Muscle and joint pains are other prominent symptoms of H3N2 infection. These pains are felt widely throughout the body and can be severe enough to make daily activities difficult. Most patients feel extremely tired and exhausted; this state of malaise can confine the person to bed.

Respiratory System Symptoms

H3N2 infection typically involves a dry and persistent cough. This cough is non-productive (without phlegm) and can sometimes last for weeks. The cough may persist even after other symptoms have subsided, negatively affecting the patient’s quality of life. Sore throat is also a common symptom and can be severe enough to cause difficulty swallowing.

While not as pronounced as in a common cold, runny nose or congestion are common findings in H3N2 infection. Headaches are usually severe and widespread. Watery and red eyes may also accompany the symptoms.

Digestive System Symptoms

The H3N2 virus primarily affects the respiratory tract, but in some cases, it can cause digestive system symptoms. Gastrointestinal symptoms such as nausea, vomiting, and diarrhea are more common, especially in children. Loss of appetite and difficulty eating may also occur.

Symptoms Seen in Risk Groups

H3N2 infection can be more severe in individuals with weakened immune systems, the elderly, those with chronic illnesses, and young children. In these risk groups, complications such as shortness of breath, chest pain, and blue discoloration of the lips and nail beds may develop. These conditions can be signs of lower respiratory tract infections like pneumonia and require urgent medical intervention.

Symptoms of H3N2 infection usually last 5-7 days. However, some symptoms, such as a cough, can continue for weeks. Recognizing the symptoms and identifying patients in the risk group is crucial for early diagnosis and the initiation of appropriate treatment.

How is the H3N2 Virus Transmitted?

The transmission characteristics of the H3N2 virus are fundamental factors determining the spread rate of this infection. The virus can spread through multiple routes and poses a significant risk to public health.

Transmission via Respiratory Droplets

The H3N2 virus primarily spreads through respiratory droplets expelled when infected individuals cough, sneeze, or talk. These droplets contain viral particles and can remain suspended in the air for distances up to about 2 meters. Infection risk occurs when people in close proximity inhale these droplets.

The area within 1 meter of an infected person carries a particularly high risk. Droplets released during coughing and sneezing are concentrated within this distance and can easily reach the respiratory tract.

Transmission via Contaminated Surfaces

The H3N2 virus has the ability to survive on various surfaces for a certain period. Frequently touched surfaces such as doorknobs, computer keyboards, phone screens, and handles on public transport can play a role in the spread of the virus.

If hands touch contaminated surfaces and are then brought to the mouth, nose, or eyes, the virus can enter the body. Direct physical contact is also a factor that increases the risk of transmission.

The risk of transmission is higher in children because they frequently touch their faces and are in close contact during play.

Infectious Period and Infection Process

The incubation period for the H3N2 virus is typically 1-4 days. However, infected individuals become contagious 24 hours before symptoms appear. This characteristic facilitates the unnoticed spread of the virus within the community.

After symptoms begin, infectivity generally lasts 5-7 days in adults. In immunocompromised individuals and children, this period can extend up to 10-14 days. During this time, it is possible for sick individuals to continue spreading the virus to those around them.

High-Risk Environments

Certain environments provide more favorable conditions for the spread of the H3N2 virus:

• Closed and crowded areas (schools, workplaces, shopping centers)
• Healthcare facilities and nursing homes
• Educational institutions, especially nurseries and primary schools
• Public transportation vehicles

The H3N2 variant that emerged in Australia in 2025 underwent 7 different mutations. These mutations have allowed the virus to partially overcome the immune system’s previous defense mechanisms.

Intra-family transmission rates are also high. A study found that in 77% of families with children hospitalized due to an H3N2-like respiratory virus, at least one other family member was also infected with the same virus.

Measures such as hand hygiene, mask use, and avoiding sick individuals can significantly reduce the spread of the virus.

How is the H3N2 Virus Diagnosed?

The diagnosis of H3N2 infection is made by a specialist doctor through clinical evaluation and laboratory tests. Since the symptoms of the H3N2 virus are similar to those of other respiratory tract infections, definitive diagnosis must be confirmed by laboratory tests.

1- What is the RT-PCR Test and How is it Applied?

The RT-PCR (Reverse Transcription Polymerase Chain Reaction) test is accepted as the standard method for diagnosing H3N2 infection. This molecular technique detects viral RNA in respiratory samples, determining the presence of the virus.

The testing process begins by sending a swab sample taken from the nose or throat area to the laboratory. In the lab, viral RNA is isolated, converted to DNA via reverse transcription, and then these DNA fragments are amplified to a detectable level.

The RT-PCR test yields results quickly and with high accuracy. This allows the H3N2 virus to be definitively distinguished from other respiratory tract diseases. Point-of-care RT-PCR tests have also been developed, enabling rapid diagnosis in clinical settings without needing to send samples to central laboratories.

2- Viral Culture and Antibody Tests

Viral culture is another approach used in H3N2 diagnosis. In this method, the virus from the patient’s sample is grown in a laboratory environment. Although the cultivation process takes longer, it definitively confirms the presence of the virus.

Antibody tests measure the immune response developed by the body against the H3N2 virus and are particularly useful for retrospectively assessing the infection. Antibodies produced by the immune system when encountering the virus can be detected through blood tests.

Rapid diagnostic tests (RIDTs) can be used as an initial screening tool and provide results within 15 minutes via nasal or throat swabs. However, these tests have lower sensitivity compared to the RT-PCR test. Advanced diagnostic approaches like the Flu-Xpert Viral Panel can simultaneously detect multiple respiratory viruses, including H3N2.

3- Points to Consider in the Diagnosis Process

The timing of the test is critically important during the H3N2 diagnosis process. Viral RNA levels are highest in the first few days after the onset of symptoms. Therefore, testing immediately after symptoms begin yields more accurate results.

Sample collection also affects the diagnosis process. Studies show that viral RNA levels are higher in nasal samples and are more frequently detected compared to oral samples. Taking the sample from the correct site increases the reliability of the test result.

Even if the initial test is negative, repeating the test is recommended if symptoms persist. The optimal time for a retest is usually 24-48 hours after the initial test. Viral load detected by PCR can be a useful marker for assessing disease severity and prognosis.

How is the H3N2 Virus Treated?

Treatment for H3N2 infection generally involves symptomatic approaches and supportive care methods. The treatment plan is determined based on the patient’s age, symptom severity, underlying health problems, and risk group status. Early diagnosis and appropriate treatment approaches in H3N2 virus infections can shorten the duration of illness and prevent complications.

1- Symptomatic Treatment Methods

The primary treatment approach for H3N2 infection is aimed at alleviating symptoms. Patients are treated with adequate rest, plenty of fluids, and fever control. Rest supports the body’s fight against the infection and reduces the risk of spreading the virus to others.

Increasing fluid intake prevents dehydration and facilitates the clearance of respiratory secretions. Warm salt water gargles can soothe a sore throat, and steam inhalation can reduce irritation in the respiratory tracts. Fever-reducing medications (paracetamol or ibuprofen) may be used upon doctor’s recommendation.

2- Antiviral Drug Treatment

Antiviral drugs can be used to treat H3N2 infection in certain circumstances. Oseltamivir (Tamiflu) is the most commonly used antiviral agent and yields the most effective results when started within the first 48 hours after symptoms begin. These drugs can shorten the duration of the illness and reduce the severity of symptoms.

Antiviral treatment is generally recommended as a priority for patients in risk groups. The treatment period is typically 5 days, and the dose is adjusted according to the patient’s age and body weight. Since antiviral drugs may have side effects, they should be used under medical supervision.

3- Conditions Where Antibiotic Use is Inappropriate

Antibiotic use is not recommended for H3N2 infection because antibiotics are ineffective against viral infections. Unnecessary antibiotic use can contribute to the development of bacterial resistance and cause side effects. Antibiotics are only used under a doctor’s supervision when secondary bacterial infections develop.

If bacterial complications such as sinusitis, otitis media, or pneumonia develop, appropriate antibiotic treatment may be necessary. This assessment must be made by a healthcare professional.

Special Treatment Approaches for H3N2 Infection Risk Groups

In some patient groups, H3N2 infection can be more severe and requires special treatment approaches. Individuals over 65, children under 5, pregnant women, immunocompromised individuals, and those with chronic diseases (cardiovascular, pulmonary, renal, hepatic diseases, and diabetes) are considered high-risk groups.

In these patients, antiviral treatment may be started earlier, and hospital monitoring may be required. Complication symptoms (shortness of breath, chest pain, drop in oxygen saturation) in risk group patients should be closely monitored, and emergency medical intervention should be provided if necessary.

The treatment of H3N2 infection is planned according to the patient’s individual condition and carried out in line with the healthcare professional’s recommendations. Monitoring symptoms throughout the treatment process and reviewing the treatment plan when necessary are important.

Key Points About the H3N2 Virus

The H3N2 virus is a subtype of the influenza A virus and can be more severe than seasonal flu infections. The virus’s symptoms typically manifest as sudden onset of high fever, muscle aches, dry cough, and extreme fatigue. Appropriate medical evaluation is important if these symptoms are noticed.

The H3N2 virus is primarily transmitted through droplets and can also spread via contaminated surfaces. Measures such as hand hygiene, mask use, and avoiding sick individuals can reduce the risk of transmission. Since the infectious period begins before symptoms appear, preventive measures should be applied regularly.

The diagnosis of H3N2 infection is made by a specialist doctor through clinical evaluation and, when necessary, laboratory tests. The RT-PCR test is considered the gold standard for the definitive diagnosis of the virus. Early diagnosis is important for determining appropriate treatment approaches.

Treatment approaches generally include symptomatic care. Rest, plenty of fluids, and fever-reducing medications may be sufficient for most patients. Antiviral drug treatment may be considered for patients in risk groups. Antibiotics are not used in H3N2 treatment because they are ineffective against viral infections.

Risk groups, including individuals over 65, children under 5, pregnant women, and those with chronic illnesses, may require more careful monitoring. Infection can be more severe in these groups, and the risk of complications may increase.

The flu vaccine can provide protection against influenza viruses, including H3N2. The effectiveness of the vaccine may vary based on annual variants but can be beneficial in reducing the severity of the illness. Annual vaccination is recommended, especially for individuals in risk groups.

Seeking medical attention when H3N2 virus symptoms are observed is crucial for accurate diagnosis and the application of appropriate treatment approaches. The determination of the treatment plan by a specialist and adherence to the recommended approaches support the recovery process.

Frequently Asked Questions About the H3N2 Virus